Biofrontera Inc. Warrants (BFRIW) stock news · rev $41.7M
Biofrontera Inc. Warrants (BFRIW) is a drug manufacturers - specialty & generic company listed on US.
This BFRIW news page leads with what Biofrontera Inc. Warrants filed — not a scraped headline mill.
No cached 8-K sentence for BFRIW yet. We will not pad this page with generic market recap.
Latest reported BFRIW revenue for 2025-12-31 was $41.7M. Net income was -$10.5M. Revenue was up 11.7% from 2024-12-31 to 2025-12-31. BFRIW currently screens at market cap $73.9K.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BFRIW stock page; for the tape open the quote page.
BFRIW stock news FAQ
What are BFRIW's latest revenue and net income?
Latest cached Biofrontera Inc. Warrants (BFRIW) revenue for Dec 31, 2025 was $41.7M. Net income was -$10.5M. Statements: https://lician.com/financials/bfriw
How did BFRIW revenue change from the prior cached period?
Cached Biofrontera Inc. Warrants (BFRIW) revenue was up 11.7% from $37.3M (Dec 31, 2024) to $41.7M (Dec 31, 2025). Statements: https://lician.com/financials/bfriw
What is BFRIW's market cap?
Biofrontera Inc. Warrants (BFRIW) market cap is $73.9K on the latest cached fundamentals snapshot.
What kind of company is BFRIW?
Biofrontera Inc. Warrants (BFRIW) is a drug manufacturers - specialty & generic company listed on US.
Where is BFRIW stock news listed?
Cached stock news for Biofrontera Inc. Warrants (BFRIW) is listed at https://lician.com/news/bfriw. Filings: https://lician.com/sec/bfriw
Not investment advice.